News Daily News P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed Yael L. Maxwell June 20, 2024
News Daily News TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable Michael O'Riordan January 09, 2024
News Daily News No Harm, No Help With Bioabsorbable-Polymer Stents: Registry Michael O'Riordan March 01, 2021
News Daily News Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis Michael O'Riordan February 10, 2020
News Daily News Debate Over BMS vs DES in High-Bleeding-Risk Scenarios Gets Fresh Fuel in Meta-analysis Yael L. Maxwell November 05, 2018
News Daily News 10-Year Follow-up of Early DES Shows Steady Risk of Late Events L.A. McKeown February 08, 2017
News Daily News Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding L.A. McKeown March 08, 2016
News Daily News Evidence of Plaque Regression Bolsters Case for Combining Ezetimibe With Statin L.A. McKeown July 29, 2015
News Daily News Meta-analysis Questions One-Size-Fits-All Anticoagulant Strategy in STEMI Patients L.A. McKeown November 17, 2014
News Daily News HEAT-PPCI Published: Discrepant Finding of Heparin’s Superiority over Bivalirudin in Primary PCI Still Puzzles Yael L. Maxwell July 17, 2014
News Daily News STEMI Patients with Large Thrombus Benefit from Low-dose Thrombolysis Yael L. Maxwell April 10, 2014
News Daily News Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type Jason Kahn January 22, 2013
News Daily News Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD L.A. McKeown September 18, 2012
News Daily News Meta-Analysis: Adjunctive Cilostazol Lowers Repeat Revascularization After PCI Caitlin E. Cox March 07, 2012
News Daily News HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen Leah Lawrence September 29, 2011
News Daily News HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics Jason Kahn July 18, 2011